Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction

Cardiology

Volumn 99, Issue 1, 2003, Pages 47-53

  Anzai, Toshihisa ^a   Yoshikawa, Tsutomu ^a   Takahashi, Toshiyuki ^a   Maekawa, Yuichiro ^a   Okabe, Teruo ^a   Asakura, Yasushi ^a   Satoh, Toru ^a   Mitamura, Hideo ^a   Ogawa, Satoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Blocker; C reactive protein; Cardiac rupture; Inflammation; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CARVEDILOL; CREATINE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY RISK; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE REVASCULARIZATION; HEART RUPTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; Q WAVE; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; VASCULAR DISEASE;

ADRENERGIC BETA-ANTAGONISTS; AGED; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CYTOKINES; FEMALE; HEART RUPTURE, POST-INFARCTION; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS;

EID: 0037277326     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068449     Document Type: Article

References (33)

1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group: Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction. Lancet 1988;i:921-923.
2. Schuster EH, Bulkley BH: Expansion of transmural myocardial infarction: A pathophysiologic factor in cardiac rupture. Circulation 1979;60:1532-1538.
3. Jugdutt BI, Michorowski BL: Role of infarct expansion in rupture of the ventricular septum after acute myocardial infarction: A two-dimensional echocardiographic study. Clin Cardiol 1987;10:641-652.
4. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-1172.
5. Marino P, Zanolla L, Zardini P (GISSI): Effect of streptokinase on left ventricular remodeling and function after myocardial infarction: The GISSI trial. J Am Coll Cardiol 1989;14:1149-1158.
6. Sheiban I, Fragasso G, Rosano GM, Dharmadhikari A, Tzifos V, Pagnotta P, Chierchia SL, Trevi G: Time course and determinants of left ventricular function recovery after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 2001;38:464-471.
7. Roberts R, Rogers WJ, Mueller HS, Lambrew CT, Diver DJ, Smith HC, Willerson JT, Knat-terud GL, Forman S, Passamani E: Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation 1991;83:422-437.
8. Basu S, Senior R, Raval U, van der Does R, Bruckner T, Lahiri A: Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction: A placebo-controlled, randomized trial. Circulation 1998;96: 1101-1109.
9. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E: Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319:80-86.
10. Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G: Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting enzyme inhibition. Lancet 1991;337:872-876.
11. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H, Ogawa S: Creactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997;96:778-784.
12. Pepys MB: C-reactive protein fifty years on. Lancet 1981;i:653-656.
13. Ikeda U, Ohkawa F, Seino Y, Yamamoto K, Hidaka Y, Kasahara T, Kawai T, Shimada K: Serum interleukin-6 level becomes elevated in acute myocardial infarction. J Mol Cell Cardiol 1992;24:579-584.
14. Murray DR, Prabhu SD, Chandrasekar B: Chronicβ-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 2000;101:2338-2341.
15. Bürger A, Benicke M, Deten A, Zimmer HG: Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts. Am J Physiol 2001;281:H14-H21.
16. Killip T, Kimball JT: Treatment of myocardial infarction in a coronary care unit. Am J Cardiol 1967;20:457-464.
17. Forrester JS, Diamond G, Chatterjee K, Swan HJ: Medical therapy of acute myocardial infarction by application of hemodynamic subsets. N Engl J Med 1976;295:1356-1362.
18. Anzai T, Yoshikawa T, Asakura Y, Abe S, Akaishi M, Mitamura H, Handa S, Ogawa S: Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction. J Am Coll Cardiol 1995;26:319-327.
19. Shiraki H, Yoshikawa T, Anzai T, Negishi K, Takahashi T, Asakura Y, Akaishi M, Mitamura H, Ogawa S: Association between preinfarction angina and a lower risk of right ventricular infarction. N Engl J Med 1998;338:941-947.
20. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB: A reporting system on patients evaluated for coronary artery disease. Circulation 1975;51:5-40.
21. The TIMI Study Group: The thrombolysis in myocardial infarction trial. N Engl J Med 1985;312:932-936.
22. Mundth E: Rupture of the heart complicating myocardial infarction. Circulation 1972;46:427-429.
23. Saffitz JE, Fredrickson RC, Roberts WC: Relation of size of transmural acute myocardial infarct to mode of death, interval between infarction and death and frequency of coronary arterial thrombus. Am J Cardiol 1986;57: 1249-1254.
24. Becker AE, van Mantgem JP: Cardiac tamponade. A study of 50 hearts. Eur J Cardiol 1974;3/4:348-358.
25. Lautsch EV, Lanks KW: Pathogenesis of cardiac rupture. Arch Pathol 1967;84:264-271.
26. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL: Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996;27:1201-1206.
27. Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M, Kinoshita M: Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 1998;31:391-398.
28. Gullestad L, Ueland T, Brunsvig A, Kjekshus J, Simonsen S, Froland SS, Aukrust P: Effect of metoprolol on cytokine levels in chronic heart failure - A substudy in the Metoprolol Controlled-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Am Heart J 2001;141:418-421.
29. Ohtsuka T, Hamada M, Hiasa G, Sasaki O, Suzuki M, Hara Y, Shigematsu Y, Hiwada K: Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol 2001;37:412-417.
30. Mabuchi N, Tsutamoto T, Kinoshita M: Therapeutic use of dopamine and beta-blockers modulates plasma interleukin-6 levels in patients with congestive heart failure. J Cardiovasc Pharmacol 2000;36:S87-S91.
31. Prabhu SD, Chandrasekar B, Murray DR, Freeman GL: β-Adrenergic blockade in developing heart failure: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000;101:2103-2109.
32. Dargie HJ: Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRI-CORN randomized trial. Lancet 2001;357: 1385-1390.
33. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S: Cytokine gene expression after myocardial infarction in rat hearts. Circulation 1998;98:149-156.